A prospective observational study of structure and visual field progression in open-angle glaucoma
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000012411
- Lead Sponsor
- Santen Pharmaceutical CO., LTD.
- Brief Summary
The analysis included 195 eyes of 115 patients [41 eyes in POAG (narrow) and 154 eyes in normal tension glaucoma (NTG)], 32 eyes in DH group, 10 eyes in migraine group, and 19 eyes in diabetic group. The mean IOP and mean MD of all groups at baseline were 13.3 plus or minus 2.2 mmHg and -6.4 plus or minus4.0 dB, respectively; the DH group had a greater proportion of NTG than the group without risk factors, but there was no significant difference in the degree of visual field impairment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 119
Not provided
Subject who has a disease which considered inappropriate from safety perspective(severe cardiovascular/ respiratory/ hepatobiliary/ digestive/ urinary/ renal/ hematological/ endocrine/ immune disease, malignant tumor, etc.) The investigator, subinvestigator determined that the person is ineligible as study subject
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method